Related Experiment Video
Updated: May 27, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Spatiotemporal effects of a possible chemorepulsion of tumor cells by immune system effectors
1Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti 435, Milano I-20141, Italy. alberto.donofrio@ifom-ieo-campus.it
Abstract:
Tumor-immune system interplay is a landmark of tumor development, and chemotactic attraction of immune system cells towards a tumor is a landmark of immune control. Since tumor cells are capable of chemotactic and chemorepulsive motion, based on a number of analogies between the behavior of tumor cells and that of bacteria, and on the production of potentially chemorepulsive semaphorins by immune systems effectors, we propose here the possibility of chemorepulsion of tumor cells, elicited by chemicals produced by immune system effectors such as macrophages and cytotoxic T lymphocytes. To study the effects of this hypothesized phenomenon within the framework of the interplay of neoplasias with the innate and adaptive immune system, we appropriately extend two well-known models: the tumor-macrophage models by Owen and Sherratt [Owen and Sherratt, J. Theor. Biol., 1998] and the Matzavinos-Chaplain model of tumor-CTL interaction [Matzavinos, Chaplain and Kuznetsov, Math. Med. Biol., 2004]. Our simulations suggest that this mechanism might allow a faster expansion of tumors, and in the concluding remarks we envisage a new possible route of immunoevasion.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
07:45Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
Published on: January 26, 2024
Related Concept Videos
The Tumor Microenvironment
Chemotaxis and Direction of Cell Migration
Tumor Immunotherapy
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cell-mediated Immune Responses
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...